Close

Consumer Insights

COVID-19 Impact on U.S. Cannabis Markets

State Status This page will be updated as new information becomes available. As Americans endure another week under the restrictions set by  government bodies as a result of the COVID-19 virus pandemic, many businesses have been forced to address their “essential” status, forcing many to temporarily close or adjust operations. […]

Read More

How Will “Cannabis 2.0” Affect the Legal Canadian Market?

Canada Map BDS Analytics

As part of our partnership with ACCRES, BDS Analytics’ President and Co-Founder, Liz Stahura, recently presented a Cannabis 2.0 webinar for Canadian Retailers. Here are our Top Five takeaways:   There’s a lot to be learned from the U.S. markets. Canada may have been first when it comes to federal […]

Read More

Due-Diligence Is Key for Betting on Cannabis in Nevada

Nevada and cannabis

The Nevada cannabis market is unique among states with legal recreational cannabis regimes. The role of tourism plays a big role in shaping retail trends. The concentration of sales in urban centers stands apart. And the state’s regulatory framework offers benefits and challenges for cannabis companies and investors. Since July […]

Read More

BDS Analytics’ Top 5: Exercise and Cannabis

Top 5 BDS Analytics

To some, cannabis and exercise may seem like an unlikely pairing. But those in the know understand that cannabis in its various forms can serve as a great pre, during, or post-workout supplement. These Top 5 insights from BDS Analytics counter the “lazy stoner” stereotype and show that cannabis often […]

Read More

CBD: Cannabidiol Breaks Out of the Legal Dispensary Channel

The latest Cannabis Intelligence Briefing from Arcview Market Research and BDS Analytics: CBD: Cannabidiol Escapes the Dispensary details CBD’s move from legal cannabis dispensaries to the general retail market. At present, the bulk (65%) of the $1.9 billion in annual spending on CBD products in the U.S. takes place through licensed […]

Read More

Pets, Pain and CBD: The Many Applications of Cannabinoid Products Webinar Recap

CBD: it spans product categories, retail channels, regulatory landscapes – and even species. Last month’s webinar covered the current cannabinoid market as it relates to pain management as well as pet care, both within the dispensary channel (CBD from marijuana) and in the general retail market (hemp-derived CBD). While pain […]

Read More

Top 5 Data Insights: Labor Day Weekend Sales

Top 5 BDS Analytics

We’re in no rush to say goodbye to summer, but, as we head into Labor Day weekend, let’s review how the cannabis industry has fared during Labor Day weekends past and other key summer holiday periods: Labor Day weekend has been a historically big for sales in the dispensary channel. […]

Read More

BDS Analytics’ Top 5 Insights From Our Upcoming Pet & Pain Webinar

Top 5 BDS Analytics

Our August webinar, Pet, Pain, and CBD: The Many Applications of Cannabinoid Products is coming up this week. Here is some of what you can expect to learn – be sure to tune in on Thursday for the full story. Register here: http://bit.ly/2MRJQbU Six in 10 Cannabis consumers use Cannabis […]

Read More

California’s Cannabis Industry is Ready to Realize Its Full Potential

BDS Analytics California: Lessons from the World's Largest Cannabis Market

Inspired by the Cannabis Intelligence Briefing Series Report: California: Lessons from the World’s Largest Cannabis Market Analysis of the emerging California adult-use market, detailed in the new Cannabis Intelligence Briefing by Arcview Market Research and BDS Analytics: “California: Lessons from the World’s Largest Cannabis Market”, tells the story of the […]

Read More

BDS Analytics’ Top 5 Insights: The Impact of Cannabis on the OTC and Prescription Drug Channels

Cannabis pharmaceutical BDS Analytics

As more U.S. states move towards legalization, cannabis consumers are taking advantage of the unique opportunity to address medical needs through the available products at their local dispensaries. Though medical cannabis is generally not covered by most U.S. insurance plans, trends indicate increased use of cannabis as an alternative to […]

Read More

Subscribe to Our Newsletter